Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.

Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in a series of transactions.

Summary

• Opko Health, Inc., a major shareholder of GeneDx Holdings Corp., has reported the sale of Class A Common Stock.
• On July 19, 2024, Opko Health sold 25,000 shares at a price of $32.29 per share.
• On July 22, 2024, they sold 50,000 shares at a weighted average price of $32.6088 per share, with individual transactions ranging from $32.00 to $33.02.
• On July 23, 2024, Opko Health sold 75,000 shares at a weighted average price of $33.4566 per share, with individual transactions ranging from $32.72 to $34.50.
• Following these transactions, Opko Health's direct ownership in GeneDx Holdings Corp. stands at 3,258,403 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the sale of shares, which is neutral in sentiment. It simply reflects transactions that have occurred.

Industry Context

Form 4 filings are standard practice when insiders or major shareholders of a publicly traded company buy or sell shares; this provides transparency to the market.

Stakeholder Impact

• The sale of shares by a major shareholder like Opko Health could potentially influence the market's perception of GeneDx Holdings Corp.

Key Dates